Durable immunogenicity of ELI-002 2P in AMPLIFY-201: Lymph node targeted mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer -April 08, 2024 at 04:52 pm EDT

Public neoantigen:


repertoire4-5


Driver:


Truncal:






...

Related Keywords

San Diego ,California ,United States ,Boston ,Massachusetts ,Christopherm Haqq ,Peterc Demuth ,Amym Tavares ,Jamesr Perry ,Lisak Mcneil ,Esther Welkowsky ,Haley Vanwyk ,Cancer Research ,Elicio Therapeutics Inc ,Thian Kheoh ,Cell Responses Correlate ,Vaccination Amplifies Cytotoxic ,Solid Human Cancers ,Promising Tumor Antigen ,Reduced Risk ,Mediant Cell Response ,Randomized Phase ,Markets ,